· Published by Health Canada · Official notice
| Brand | Lot | Product Name | Market Authorization | Dosage | Strength |
|---|---|---|---|---|---|
| I-131 Diagnostic Capsule | D030-20231101-BLU5; D030-20231108-PNK1; D100-20231108-PNK9; D030-20231115-YEL1; D100-20231115-YEL9; D030-20231122-BRN1; D100-20231122-BRN9; D030-20231108-PNK5; D030-20231122-BRN5; D030-20231129-GRN1; D100-20231129-GRN9; D030-20231129-GRN5; D030-20231206-BLU1; D100-20231206-BLU9; D030-20231206-BLU5; D030-20231213-PNK1; D100-20231213-PNK9; D030-20231220-PNK5; D030-20231220-YEL1; D030-20231227-BRN1; D100-20231220-YEL9; D100-20231227-BRN9; D030-20231227-BRN5; D030-20240103-GRN1; D100-20240103-GRN9; D030-20240103-GRN5; D030-20240110-BLU1; D100-20240320 -BLU9; D030-20240110-BLU5; D030-20240117-PNK1; D100-20240117-PNK9; D030-20240117-PNK5; D030-20240124-YEL1; D100-20240124-YEL9; D030-20240124-YEL5; D030-20240131-BRN1; D100-20240131-BRN9; D030-20240131-BRN5; D030-20240207-GRN1; D100-20240207-GRN9; D030-20240207-GRN5; D030-20240214-BLU1; D100-20240214-BLU9; D030-20240214-BLU5; D030-20240221-PNK1; D100-20240221-PNK9; D030-20240221-PNK5; D030-20240228-YEL1; D100-20240228-YEL9; D030-20240228-YEL5; D030-20240306-BRN1; D100-20240306-BRN9; D030-20240306-BRN5; D030-20240313-GRN1; D100-20240313-GRN9; D100-20240320-BLU9; D030-20240313-GRN5; D030-20240320-BLU1; D100-20240327-PNK9; D030-20240327-PNK1; D030-20240327-PNK2; D100-20240403-YEL9; D030-20240320-BLU5; D030-20240403-YEL1; D030-20240327-PNK5 | I-131 Diagnostic Capsule | No market authorization | Capsule | 30uCi to 100uCi at time of calibration |
Affected lots may have decreased thyroid uptake.